Abstract

SKINmed: Dermatology for the ClinicianVolume 7, Issue 2 p. 84-85 Xyzal (levocetirizine dihydrochloride) William Abramovits MD, William Abramovits MD Baylor University Medical Center1 and the University of Texas Southwestern Medical School,2Dermatology Treatment & Research Center,3Dallas, TX; and the Sunnybrook Health Sciences Center, University of Toronto, Toronto,4 and Mediprobe Research Inc, London,5 Ontario, CanadaSearch for more papers by this author 1,2,3 Aditya Gupta MD, PhD, Aditya Gupta MD, PhD Baylor University Medical Center1 and the University of Texas Southwestern Medical School,2Dermatology Treatment & Research Center,3Dallas, TX; and the Sunnybrook Health Sciences Center, University of Toronto, Toronto,4 and Mediprobe Research Inc, London,5 Ontario, CanadaSearch for more papers by this author 4,5 William Abramovits MD, William Abramovits MD Baylor University Medical Center1 and the University of Texas Southwestern Medical School,2Dermatology Treatment & Research Center,3Dallas, TX; and the Sunnybrook Health Sciences Center, University of Toronto, Toronto,4 and Mediprobe Research Inc, London,5 Ontario, CanadaSearch for more papers by this author 1,2,3 Aditya Gupta MD, PhD, Aditya Gupta MD, PhD Baylor University Medical Center1 and the University of Texas Southwestern Medical School,2Dermatology Treatment & Research Center,3Dallas, TX; and the Sunnybrook Health Sciences Center, University of Toronto, Toronto,4 and Mediprobe Research Inc, London,5 Ontario, CanadaSearch for more papers by this author 4,5 First published: 06 May 2008 https://doi.org/10.1111/j.1751-7125.2008.08173.xRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume7, Issue2March/April 2008Pages 84-85 RelatedInformation

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.